REP20 Pfizer (Relpax 20 mg)

Generic Name: eletriptan

Pill imprint REP20 Pfizer has been identified as Relpax 20 mg.

Relpax is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Relpax 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for REP20 Pfizer

Relpax 20 mg REP20 Pfizer
Relpax 20 mg REP20 Pfizer Front
Relpax 20 mg REP20 Pfizer Back
Relpax
Generic Name:
eletriptan
Imprint:
REP20
Pfizer
Strength:
20 mg
Color:
Orange
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimigraine agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00049-2330
Inactive Ingredients:
microcrystalline cellulose
lactose
croscarmellose sodium
magnesium stearate
titanium dioxide
hypromelloses
triacetin
FD&C Yellow No. 6
aluminum oxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)